News
Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...
Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...
TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in ...
3d
InvestorsHub on MSNTonix Pharmaceuticals Shares Climb on Encouraging TNX-801 Vaccine ResultsTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company, announced that Dr. Sina Bavari, Executive Vice President of Infe ...
Read about Tonix Pharmaceuticals Holding Corp (TNXP:XNAS) stock and today's latest news and financial updates.
Find the latest SEC Filings data for Tonix Pharmaceuticals Holding Corp. Common Stock (TNXP) including 10-K and 10-Q forms at Nasdaq.com.
Find the latest on short interest, settlement dates, average share volume, and days to cover for Tonix Pharmaceuticals Holding Corp. Common Stock (TNXP) at Nasdaq.com.
Interactive chart for Tonix Pharmaceuticals Holding Corp. (TNXP) – analyse all of the data with a huge range of indicators.
Stock analysis for Tonix Pharmaceuticals Holding Corp (TNXP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results